Algernon Pharmaceuticals Stock Analysis

Algernon OTC Stock Analysis Notes

About 15.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Algernon Pharmaceuticals recorded a loss per share of 2.28. The entity last dividend was issued on the 17th of October 2018. The firm had 1:100 split on the 24th of November 2021. Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. Algernon Pharmaceuticals is traded on OTC Exchange in the United States.The quote for Algernon Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Algernon Pharmaceuticals please contact Christopher Moreau at 604 398 4175 or go to https://algernonpharmaceuticals.com.

Algernon Pharmaceuticals Investment Alerts

Algernon Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Algernon Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Algernon Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 27th of March, Algernon Pharmaceuticals shows the risk adjusted performance of 0.0972, and Mean Deviation of 5.22. Algernon Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Algernon Pharmaceuticals, which can be compared to its peers. Please confirm Algernon Pharmaceuticals standard deviation and the relationship between the treynor ratio and kurtosis to decide if Algernon Pharmaceuticals is priced correctly, providing market reflects its regular price of 0.0645 per share. As Algernon Pharmaceuticals appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Algernon Pharmaceuticals Price Movement Analysis

Algernon Pharmaceuticals Predictive Daily Indicators

Algernon Pharmaceuticals Forecast Models

Algernon Pharmaceuticals' time-series forecasting models are one of many Algernon Pharmaceuticals' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Algernon Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Algernon Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Algernon shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Algernon Pharmaceuticals. By using and applying Algernon OTC Stock analysis, traders can create a robust methodology for identifying Algernon entry and exit points for their positions.

When running Algernon Pharmaceuticals' price analysis, check to measure Algernon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Algernon Pharmaceuticals is operating at the current time. Most of Algernon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Algernon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Algernon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Algernon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.